scholarly journals Clinical and Antibody Characteristics Reveal Diverse Signatures of Severe and Non-severe SARS-CoV-2 Patients

2021 ◽  
Author(s):  
Hongye Wang ◽  
Dongshan Yan ◽  
Ya Li ◽  
Yanfei Gong ◽  
Yulin Mai ◽  
...  
Keyword(s):  
Immune Responses ◽  
Protein S ◽  
Strongly Correlated ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Response Characteristics ◽  
Reactive Protein ◽  
Blocking Rate ◽  
Binding Inhibition ◽  
Severe Group

Abstract Clinical and Immune response characteristics of COVID-19 between severe and non-severe patients have not been fully clarified. In this study, clinical features, antibody responses targeting SARS-CoV-2 spike protein (S) and its different domains, Ig isotypes and IgG subtypes, ACE2 competitive antibodies, binding titers with FcγIIa and FcγIIb receptors, and 14 cytokines were investigated in 119 serum samples from 37 PCR-confirmed COVID-19 patients. Severe group including 9 patients represented lower lymphocyte count, higher neutrophil count, higher level of LDH, total bile acid (TBA) (P<1×10-4), r-glutaminase (P=0.011), adenosine deaminase (P<1×10-4), procalcitonin (P=0.004), C-reactive protein (P<1×10-4) and D-dimer (P=0.049) compared to non-severe group (28 patients). Significantly, higher-level antibody targeting S (IgA, IgM, and IgG), different S domains specificity (RBD, RBM, NTD, and CTD), FcγIIa and FcγIIb binding capability were observed in severe group than that of non-severe group, of which IgG1 and IgG3 were the main IgG subclasses. RBD-IgG were strongly correlated with S-IgG both in severe group and non-severe group. Additionally, CTD-IgG were strongly correlated with S-IgG in non-severe group. Positive RBD-ACE2 binding inhibition was strongly associated with high titers of antibody (S-IgG1, S-IgG3, NTD-IgG) especially RBD-IgG and CTD-IgG in severe group, while in non-severe group, S-IgG3, RBD-IgG and NTD-IgG titer correlated with ACE2 blocking rate. S-IgG1 was negatively associated with illness days in severe group (r=- 0.434, P=0.002), while S-IgG3 in severe group (r=0.363, P=0.011) and S-IgG1 (r=0.417, P=3×10-4) in non-severe group was positively associated with days after symptom onset. Moreover, GRO-α, IL-6, IL-8, IP-10, MCP-1, MCP-3, MIG, and BAFF were also significantly elevated in severe group. Overall, the results indicated different signatures in clinical and immune responses between the COVID-19 severe group and non-severe group, which will be markedly contributed to future therapeutic and preventive measures development.

scholarly journals Studying the Role of C-Reactive Protein in Patients with Sleeve Gastrectomy in Baghdad

2021 ◽  
Vol 3 (1) ◽  
pp. 55-60
Author(s):  
Mohammed Abbas Fadil ◽  
Raya Ezat Maroof ◽  
Moayed Abbas Fadil
Keyword(s):  
Sleeve Gastrectomy ◽  
Healthy Person ◽  
Control Group ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Reactive Protein ◽  
Medical City ◽  
Healthy Control ◽  
And Control

Obesity and severe obesity are increasing serious health problems with an epidemic percentage in most countries. In Sleeve gastrectomy, a part of the stomach structure is removed, limiting its capacity by about two to three. A total of thirty blood samples were collected from patients with obesity and the result was compared with healthy person throughout the time from November 2019 to September 2020. Before sleeve gastrectomy and after more than 6 months of sleeve surgery, the sample was collected from the Medical City/Baghdad Teaching Hospital, the withdrawal was again taken at home to have pre and post sleeve gastrectomy, Patient age ranged between [20-46] years for obese patients and healthy control. Then the serum samples were obtained from patients and control group to screen for C-reactive protein by agglutination method. The result of the present study found that the positivity of CRP in pre-operation is higher than that of post-operative with high significance [P<0.005].

scholarly journals Evidence for the use of the Alere Afinion™ AS100 for measuring the levels of C-reactive protein in an elderly South African population

2020 ◽  
pp. 71-76
Author(s):  
I Mpofana ◽  
M Nyirenda ◽  
N Abbai
Keyword(s):  
Linear Regression Analysis ◽  
Reference Method ◽  
Altman Analysis ◽  
Concordance Correlation ◽  
Excellent Correlation ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Cvd Risk ◽  
Bland Altman Analysis ◽  
Reactive Protein

Introduction: This study evaluated the performance of the Alere Afinion™ AS100 analyser for the measurement of C-reactive protein (CRP) levels in a population of older adults from South Africa. Methods: This study was a sub-study of the Sexual Health, HIV infection and comorbidity with non-communicable diseases among Older Persons (SHIOP) study. The median age of SHIOP participants was 61 years (interquartile range 12). Serum samples collected through SHIOP were used to measure CRP levels on the Alere Afinion™ AS100 (Point-of-care) and ABX Pentra 400 (reference method), respectively. Bland–Altman analysis and Lin’s concordance correlation coefficients were used to assess the agreement between the two analysers. Results: A total of 183 serum samples were tested in the study. The Alere Afinion™ AS100 median values for CRP were 9.5 mg/L and 11.5 mg/L in women and men respectively (p = 0.275). The ABX Pentra 400 median levels were lower with 5.6 mg/L and 3.6 mg/L for women and men (p = 0.027), respectively. Bland–Altman analysis and linear regression analysis showed an excellent correlation between the Pentra and Afinion analysers, with a Lin’s concordance correlation coefficient of 0.971. The Alere Afinion™ AS100 was able to correctly classify > 90% (165/183) of the CRP results when compared to the ABX Pentra 400. Conclusion: This study showed that the Alere Afinion™ AS100 had an excellent correlation with a standard laboratory method. However, the Afinion™ AS100 did not correlate well at elevated CRP levels. This may not be clinically significant since the cut-points for CVD risk are at much lower levels.

C-reactive Protein Is a More Sensitive and Specific Marker for Diagnosing Bacterial Infections in Systemic Lupus Erythematosus Compared to S100A8/A9 and Procalcitonin

2012 ◽  
Vol 39 (4) ◽  
pp. 728-734 ◽  
Author(s):  
HYOUN-AH KIM ◽  
JA-YOUNG JEON ◽  
JEONG-MI AN ◽  
BO-RAM KOH ◽  
CHANG-HEE SUH
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Bacterial Infections ◽  
Area Under The Curve ◽  
Specific Marker ◽  
Operating Characteristics ◽  
C Reactive Protein ◽  
Systemic Lupus ◽  
Serum Samples ◽  
Reactive Protein

Objective.C-reactive protein (CRP), S100A8/A9, and procalcitonin have been suggested as markers of infection in patients with systemic lupus erythematosus (SLE). We investigated the clinical significance of these factors for indication of infection in SLE.Methods.Blood samples were prospectively collected from 34 patients with SLE who had bacterial infections and 39 patients with SLE who had disease flares and no evidence of infection. A second set of serum samples was collected after the infections or flares were resolved.Results.CRP levels of SLE patients with infections were higher than those with flares [5.9 mg/dl (IQR 2.42, 10.53) vs 0.06 mg/dl (IQR 0.03, 0.15), p < 0.001] and decreased after the infection was resolved. S100A8/A9 and procalcitonin levels of SLE patients with infection were also higher [4.69 μg/ml (IQR 2.25, 12.07) vs 1.07 (IQR 0.49, 3.05) (p < 0.001) and 0 ng/ml (IQR 0–0.38) vs 0 (0–0) (p < 0.001), respectively]; these levels were also reduced once the infection disappeared. In the receiver-operating characteristics analysis of CRP, S100A8/A9, and procalcitonin, the area under the curve was 0.966 (95% CI 0.925–1.007), 0.732 (95% CI 0.61–0.854), and 0.667 (95% CI 0.534–0.799), respectively. CRP indicated the presence of an infection with a sensitivity of 100% and a specificity of 90%, with a cutoff value of 1.35 mg/dl.Conclusion.Our data suggest that CRP is the most sensitive and specific marker for diagnosing bacterial infections in SLE.

scholarly journals Detection of C-Reactive Protein Using Histag-HRP Functionalized Nanoconjugate with Signal Amplified Immunoassay

Nanomaterials ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 1240
Author(s):  
Mohd Farhan Siddiqui ◽  
Zeeshan Ahmad Khan ◽  
Seungkyung Park
Keyword(s):  
Detection Methods ◽  
Enzyme Linked Immunosorbent Assay ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Reactive Protein ◽  
Elisa Format ◽  
Early Biomarker ◽  
Cost Efficient ◽  
Detection Of Biomarkers ◽  
Gold Nanoprobe

Ultrasensitive detection of biomarkers is highly significant for disease prognosis and public health treatment. Despite wide acceptance in routine laboratory tests, the conventional enzyme-linked immunosorbent assay (ELISA) has been of limited use for early biomarker detection due to insufficient sensitivity and multiple long incubation time. Several nanoprobes have been introduced to circumvent the limitation, however, rapid, simple, and chemical-free nanoprobe synthesis and sensitive detection methods, particularly for ELISA, are still lacking. In this study, we have synthesized a gold nanoprobe, conjugated with multiple 6X-histidine (6X-his) peptide and nickel-horseradish peroxidase (Ni2+-HRP), for enhancing the colorimetric signal in ELISA. The developed nanoprobe has been tested for the detection of immunologically significant C-reactive protein (CRP) in ELISA format. The performance of designed probe is validated by testing standard and serum samples, and the detection limit of 32.0 pg/mL with R2 = 0.98 is confirmed. Furthermore, a comparative analysis of the developed nanoprobe was performed with ELISA developed on conventional guidelines, the proposed immunoassay showed an increase of 12-fold sensitivity for detecting CRP due to the high loading of 6Xhis peptide and binding of multiple Ni2+-HRP on a gold nanoparticle. Additionally, the proposed assay provides a simple, fast, and cost-efficient (not requiring multiple antibodies) detection of CRP with easy nanoprobe synthesis. Moreover, the developed Histag-HRP functionalized nanoconjugate immunoassay is flexible and can be applied to other biomarkers efficiently by using disease specific antibody.

scholarly journals 1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S629-S629
Author(s):  
Supavit Chesdachai ◽  
Nicole Engen ◽  
Joshua Rhein ◽  
Lillian Tugume ◽  
Tadeo kiiza. Kandole ◽  
...  
Keyword(s):  
Cryptococcal Meningitis ◽  
Surrogate Marker ◽  
First Episode ◽  
Event Analysis ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Hiv Viral Load ◽  
Baseline Serum ◽  
Reactive Protein ◽  
Serum Crp

Abstract Background C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to systemic inflammation. CRP is a helpful surrogate biomarker widely used in various infections, particularly for following the progression and resolution of infection. We aimed to determine the association between baseline CRP level and cryptococcal meningitis outcome. Methods We reviewed 168 prospectively enrolled HIV-infected Ugandans with confirmed first-episode cryptococcal meningitis. Baseline serum samples collected within 5 days from diagnosis had CRP levels measured and categorized into quartiles. We compared baseline serum CRP with 18-week survival using unadjusted time-to-event analysis. Results Of 168 participants, the first quartile of baseline serum CRP was 83.6 mg/L. Baseline CD4 count, HIV viral load, and cerebrospinal fluid results did not differ by quartile. Participants with CRP > 49.5 mg/L more likely presented with Glasgow Coma Scale <15 (P = 0.03). The 18-week mortality rate was 54.8% (46/84) in the highest two quartile CRP groups (49.5 mg/L), 40.5% (17/42) in the mid-range CRP group (29–49.5 mg/L), and 14.3% (6/42) in the low CRP group (<29 mg/L) (P < 0.001) (Figure 1). Conclusion Higher baseline serum CRP is associated with increased mortality in HIV-infected individuals with first-episode cryptococcal meningitis. The serum CRP could be a surrogate marker for undiagnosed co-infections or may reflect immune dysregulation leading to worse outcomes in persons with advanced AIDS and concomitant cryptococcal meningitis. Additional studies investigating more specific inflammatory biomarkers and the longitudinal trend in CRP with effective therapy would be informative. Disclosures All authors: No reported disclosures.

C-reactive protein reduces protein S-nitrosylation in endothelial cells

2012 ◽  
Author(s):  
Xinhong Wang ◽  
Weimin Liu ◽  
Yue Wu ◽  
Xiaojun Liu ◽  
Xiao Liang ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Protein S ◽  
C Reactive Protein ◽  
Reactive Protein

Development of Prothrombotic Repertoire with Progressive HIV Disease: Data from the Women’s Interagency HIV Study (WIHS).

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1057-1057
Author(s):  
Alexandra M. Levine ◽  
Cheryl Vigen ◽  
Jay Gravink ◽  
Howard A. Liebman
Keyword(s):  
Factor Viii ◽  
Lupus Anticoagulant ◽  
Protein S ◽  
Hiv Disease ◽  
C Reactive Protein ◽  
Factor Viii Activity ◽  
Functional Protein ◽  
Reactive Protein ◽  
History Of ◽  
Hiv Negative

Abstract HIV infected patients may be at increased risk for VTE, as shown by case reports, and a recent retrospective, longitudinal medical record review of approximately 42,000 HIV-infected individuals (Sullivan, 2000). There is a well documented association between acute and chronic inflammation and activation of the hemostatic system. Inflammatory cytokines such as TNF alpha, IL-1 and IL-6 have been shown to activate coagulation via the Tissue Factor pathway. Inflammation can also result in a decrease in functional Protein S, and in an increase in Factor VIII coagulant protein. We hypothesized that the inflammatory state associated with more advanced HIV disease would be associated with hemostatic activation, and clinical development of VTE over time. Methods: We assayed plasma for factor VIII activity levels, functional protein S activity, presence of lupus anticoagulant, and C reactive protein levels in a group of 96 HIV infected women and 50 HIV negative women from the Women’s Interagency HIV Study (WIHS). All assays were performed blinded to subjects HIV status. This cross sectional sample of WIHS participants from the Los Angeles site were studied at their second study visit (1994-5). The sample was selected to represent the following groups: (1) History of clinical AIDS, CD 4&lt; 200; (2) CD4 &lt; 200, no clinical AIDS; (3) HIV positive, CD4 &gt; 200; HIV-negative. Pts were excluded if they were taking any hormones or contraceptives; had been pregnant within 6 weeks of study; had any acute, active infection at the time of study visit. Hemostatic data were correlated with HIV viral load, CD4 cell count, history of clinical AIDS, history of anti-retroviral and other medication use, and levels of serum and plasma C reactive protein (CRP). Results are depicted below for median (inter-quartile range) values, adjusted for age: Group Protein S Factor VIII Serum CRP# 1. Clinical AIDS, CD4 &lt; 200 46* (40,65) 212* (174,253) 2.0 (0.5,4.8) 2. No Clinical AIDS, CD4 &lt; 200 62^ (55,67) 196+ (150, 234) 0.8 (0.7,2.7) 3. HIV+, No Clinical AIDS, CD4 &gt; 200 67.5 (59,83) 154^ (111,202) 0.9 (0.4, 3.3) 4. HIV Negative 75.5 (66,85) 116.5 (97,154) 1.85 (0.8, 5.1) Models were adjusted for age. Groups are significantly different from HIV negative participants (group 4) at the indicated p-values, determined using Scheffe adjustment * p&lt;0.0001 ^p&lt;.05 + p&lt;.001 # CRP Medians are not significantly different for the different groups. No patient or control was found to have a positive assay for the Lupus anticoagulant. We conclude: (1) Increasing progression of HIV disease, from asymptomatic, to immunologic (CD 4&lt; 200) and then clinical AIDS, is associated with progressive increase in factor VIII activity, and decrease in functional protein S; (2) This progressive hemostatic changes were not associated with elevated CRP levels, suggesting that IL-6 is not involved in this process; (3) An increase in VTE is biologically plausible in the setting of HIV infection; (4) Further prospective study is warranted to determine the full range of hemostatic abnormalities associated with HIV, and to determine any correlation between these abnormalities and development of VTE in time.

Serum C-reactive protein and immune responses in dogs inoculated withBordetella bronchiseptica (phase I cells)

1994 ◽  
Vol 18 (5) ◽  
pp. 347-357 ◽  
Author(s):  
S. Yamamoto ◽  
T. Shida ◽  
M. Honda ◽  
Y. Ashida ◽  
Y. Rikihisa ◽  
...  
Keyword(s):  
Immune Responses ◽  
Phase I ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
I Cells

scholarly journals Study of oxidative stress and C-Reactive protein in type-2 Diabetes Mellitus

2019 ◽  
Vol 7 (10) ◽  
pp. 3751
Author(s):  
Shubhangi M. Dalvi ◽  
Chandrakiran D. Hathial ◽  
Neelam Yeram ◽  
Mayuri Nalavade ◽  
Vinayak W. Patil
Keyword(s):  
Oxidative Stress ◽  
Diabetes Mellitus ◽  
Acute Phase ◽  
Metabolic Diseases ◽  
Acute Phase Reactant ◽  
Low Grade ◽  
Newly Diagnosed ◽  
C Reactive Protein ◽  
Serum Samples ◽  
Reactive Protein

Background: Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion and insulin action or both. T2DM is associated with chronic low grade inflammation, possibly through a pathway involving a cytokine-mediated acute-phase response to infection and other inflammatory processes. authors aim to study C-reactive protein (CRP) which is an acute-phase reactant produced primarily in the liver hepatocytes. Oxidative stress levels in newly diagnosed T2M patients were analysed with respect to malondialdehyde (MDA) and nitric oxide (NO).Methods: Case-control study comprising of aged-sex matched subjects: newly diagnosed T2DM cases (n=30) and controls (n=30). The serum samples of subjects were analysed for levels of MDA by Buege and Aust method, while NO levels by Cortas and Wakid’s kinetic cadmium reduction method using spectrophotometer. CRP levels were analysed by using turbidimetry. Statistical analysis was done using Mini-tab 17 software with 95% confidence interval.Results: Serum levels of MDA, NO and CRP in newly diagnosed T2DM patients were significantly increased as compared to healthy controls.Conclusions:  Authors concluded that the oxidative stress and inflammation plays a pivotal role in the aetiology of hyperglycemia in T2DM. Oxidative stress and inflammatory markers might help prognosis of T2DM in hyperglycemic individuals with the help of which precautionary measure can be taken to reduce the rate of disease progression. Treatment involving anti-oxidant and anti-inflammatory medications might help to rescue vital organs from damage.

Sign in / Sign up

Export Citation Format

Share Document